New Smartwatch Unveils Cardiac Arrest Screening & Continuous Health Monitoring

The smartwatch includes standard health features expected from a modern smartwatch, including continuous heart rate monitoring, blood oxygen measurement, sleep analysis, and stress tracking.

Honor, a China-based electronics company, has unveiled the Watch GS 5, a new smartwatch, featuring cardiac arrest screening with continuous long-term health monitoring.

The launch comes at a time when smartwatch makers are increasingly shifting toward digital health, as wearables evolve from step counters into tools that promise early risk detection.

Over the past decade, brands such as Apple, Samsung, and Huawei have added features such asECG recording, blood oxygen tracking, and irregular rhythm alerts. Honor’s approach with the GS 5 builds on this trend, with a specific focus on cardiovascular risk screening.

The Watch GS 5 with an “industry-first” sudden cardiac arrest screening feature analyzes long-term heart rhythm patterns along with “heart deceleration capacity,” a clinical-style metric associated with how effectively the heart slows down and recovers after stress.

Honor has emphasized that these features are intended for risk assessment and early warning, not for clinical diagnosis.

Beyond advanced heart tracking, the smartwatch includes standard health features expected from a modern smartwatch, including continuous heart rate monitoring, blood oxygen measurement, sleep analysis, and stress tracking.

It also offers alerts for irregular heart rhythms, potential atrial fibrillation, and sleep apnoea risk, expanding its role as a round-the-clock health companion. The extended battery life is designed to support uninterrupted health data collection.

While Honor has not confirmed timelines for global availability, previous GS-series launches suggest that an international rollout could follow, subject to regulatory approvals for health features.

Stay tuned for more such updates on Digital Health News